psoriasis) and psychosocial conditions (e.g., depressive syndrome) 2,3
If patients are not monitored, these issues can hide behind the headline of successful weight loss. No Standard Nutrition Monitoring Framework Exists for GLP-1 Drugs Currently no consensus guidelines for micronutrient monitoring in patients receiving GLP-1 receptor agonists are in place
Aron Medical Weight Loss Center, 7032 4th Avenue, NY, NY 11209 Oksana Aron, M.D., Medical Weight Loss, 347 5th Avenue, Suite 1402-200, New York NY 10016 Start now Book your initial consultation and start losing weight.
Advanced considerations for experienced users If you have been on GLP-1 therapy for several months and have a stable side effect profile, there are some nuances worth understanding about injection timing flexibility